ICON PLC (ICLR) vs Revvity Inc. (RVTY)

ICON PLC and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $16.8B against $13.4B — 1.3× the size. Revvity Inc. trades at the lower P/E: 72.0× against 257×. Revvity Inc. grew revenue faster over the last twelve months: 4.05% against 3.26%. Revvity Inc. has the higher net margin (8.16% vs 0.51%) and the higher return on invested capital (2.38% vs 1.57%). Across the 22 metrics below, Revvity Inc. leads on 13 and ICON PLC on 9.

Valuation

Metric ICLR RVTY Diagnostics & Research median
P/E 257.44 71.96 33.95
P/S 1.60 5.79 4.87
P/B 1.41 2.33 3.12
Price to free cash flow 14.98 29.84 34.02
EV/EBITDA 23.55 24.55 25.20
EV/Sales 1.89 6.54 5.66
Earnings yield 0.39% 1.39% (1.75%)
Free cash flow yield 6.67% 3.35% (0.13%)

Profitability

Metric ICLR RVTY Diagnostics & Research median
Gross margin 23.91% 54.98% 50.89%
Operating margin 3.57% 12.32% (8.57%)
Net margin 0.51% 8.16% (6.37%)
Free cash flow margin 10.66% 19.58% 0.00%
Return on equity 0.45% 3.21% (2.92%)
Return on assets 0.26% 1.95% (6.71%)
Return on invested capital 1.57% 2.38% 0.00%

Growth

Metric ICLR RVTY Diagnostics & Research median
Revenue growth (TTM) 3.26% 4.05% 7.69%
EPS growth (last fiscal year) (69.57%) (5.91%) —
Revenue growth, 5-year CAGR 24.15% 1.41% 7.40%
Net income growth, 5-year CAGR (7.15%) (19.82%) 0.00%

Health

Metric ICLR RVTY Diagnostics & Research median
Debt to equity 0.36 0.44 0.11
Current ratio 0.95 1.80 2.02
Net debt to EBITDA 3.34 3.00 0.78

Dividend

Metric ICLR RVTY Diagnostics & Research median
Dividend yield — 0.27% 0.70%
Payout ratio 0.00 0.05 0.00

Size

Metric ICLR RVTY Diagnostics & Research median
Market cap 13.42b 16.81b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack